Together, these data indicate that tumour cell-autonomous expression of BTNL2 plays a major role in tumour escape from immunosurveillance in the TME, and we think that the non-tumour cell-expressed BTNL2 plays a less important role in this process. The gene discussed is BTNL2; the disease is neoplasm.